amaranth

(redirected from Amarantus)
Also found in: Dictionary, Thesaurus, Encyclopedia.

am·a·ranth

, amaranthum (am'ă-ranth, am-ă-ran'thŭm), [C.I. 16185]
An azo dye; a soluble reddish-brown powder that turns magenta red in solution; used as a food, pharmaceutical, and cosmetic coloring agent, and occasionally in histology.
[G. amaranthon, a never-fading flower]

am·a·ranth

(am'ă-ranth)
A weed (Amaranthus) of widespread geographic distribution; some species are consumed as a foodstuff; its prolific ability to produce seed allows its use as a flour. Purported value both internally and externally (e.g., astringent).
Synonym(s): love-lies-bleeding, red cockscomb.
[G. amaranthon, a never-fading flower]
References in periodicals archive ?
In addition, Amarantus has completed various licenses and exclusive option agreements with leading universities to therapeutic applications for MANF in ophthalmology, diabetes and various undisclosed indication-specific therapeutic applications.
It's important for the military to get access to a product like this because the military is putting its soldiers in harm's way," said Gerald Commissiong, president and CEO of Amarantus.
Amarantus is uniquely positioned to improve both the diagnosis and treatment of Alzheimer's disease.
Generex said Tuesday it would license its RapidMistT technologies to Amarantus, a California biotechnology company, in a $10 million deal including Amarantus stock.
We are continuing to discuss partnership opportunities with Amarantus and look forward to collaborating further in 2013.
In addition to skin substitute therapies; rare disease & conditions, human genetics, cystic fibrosis and cancer immunotherapy advancements are leading the biotech sector led by Amarantus Bioscience Holdings, Inc.
OTCBB: RBCC) joint venture target Amarantus Bioscience, Inc.
Representatives from top pharma, medical device and biotech companies as well as CROs led presentations and case studies including Nestle, ClinTec International, Isis Pharmaceuticals, inVentiv Health, Biosense Webster, Janssen, Amarantus BioScience, Cerbomed, and others.
One of the most exciting developments this year was the deepening relationship between our company and Amarantus BioSciences.
OTCBB: RBCC) nears a new joint venture agreement to commercialize advances made by Amarantus BioSciences (OTCBB: AMBS), the company's latest target continues to seek out additional investment capital from high-profile investors.